Mednow Announces the Graduation to OTCQX Trading, to Expand Access to U.S. Investors

Mednow Inc. ("Mednow'' or the "Company") (TSXV: MNOW) (OTCQX:MDNWF), Canada's on-demand virtual pharmacy, is pleased to announce that its common shares are now trading on the OTCQX Best Market under the ticker symbol of MDNWF. The OTCQX Best Market is the highest market tier of OTC Markets, which operated markets on which 12,000 U.S. and global securities trade. Trading on OTCQX will enhance the visibility and accessibility of the Company to U.S. investors. Mednow's common shares will continue to trade on the TSX Venture Exchange under the symbol MNOW.

The OTCQX Best Market provides value and convenience to U.S. investors, brokers and institutions seeking to trade MDNWF. The OTCQX Best Market is OTC Markets Group's premier market for established, investor-focused U.S. and international companies. To be eligible, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, be current in their disclosure, and have a professional third-party sponsor introduction.

"We are pleased to reach the milestone of graduating to trading on OTCQX, as this will make it easier for our U.S. investors to invest in Mednow by reducing the requirement of having a Canadian trading account," confirmed Karim Nassar, the CEO of Mednow.

About Mednow Inc.

Mednow is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow.ca provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow's services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer, and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmarttm system that packages prescriptions, and vitamins by date and time, and doctor consultations.

To learn more, follow Mednow on Facebook, Twitter, LinkedIn, and Instagram, or visit our website at www.mednow.ca/.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements:

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information, including statements relating to: Mednow's plan to expand its operations and open fulfillment centres in certain locations in 2022, Mednow's goal of integrating the technology of its strategic business acquisitions with its core fulfillment pharmacies, the optimization of Mednow's PillSmart^TM and nutraceutical offerings, Mednow's ability to connect with employers, specialty doctors and large pharmacies, and Mednow's ability to acquire customers and lower costs.

Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that Mednow will be successful in opening additional fulfillment centres, integrating and optimizing technologies, growing its network of patients, doctors and pharmacies, and lowering costs. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, that Mednow will not be successful in opening additional fulfillment centres, integrating and optimizing technologies, expanding its network of clients and partners, and other risk factors set out in the Company's final long form prospectus dated February 26, 2021 available for review on the Company's profile at www.sedar.com. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.